Medpace Holdings (MEDP) Net Margin (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Net Margin came in at 17.16% in Q2 2026, up 220.0% on a YoY basis from 5.36% in Q2 2025, and down 2.13% quarter-over-quarter from 17.53% in Q1 2026.
Powered by 
Analysis
Medpace Holdings (MEDP) Net Margin (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Net Margin for 12 consecutive years, with 17.16% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Margin rose 220.0% year-over-year to 17.16%; the trailing twelve-month figure through Jun 2026 stood at 17.67% (down 108.0% YoY), and the FY2025 full-year result was 17.83%, down 134.0% from the prior year.
- Net Margin slipped to 17.16% in Q2 2026 per MEDP's latest filing, from 17.53% in the prior quarter.
- Across five years, Net Margin topped out at 21.81% in Q4 2024 and bottomed at 13.25% in Q2 2023.
- Historically, Net Margin has averaged 17.23% across 5 years, with a median of 17.18% in 2022.
- The sharpest annual moves came in 2024 and 2026: Net Margin soared 610 bps in 2024, then slumped 299 bps in 2026.
- Over 5 years, Net Margin stood at 17.42% in 2022, then decreased by 10 bps to 15.71% in 2023, then surged by 39 bps to 21.81% in 2024, then slipped by 13 bps to 19.07% in 2025, then slipped by 10 bps to 17.16% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 17.16%, 17.53%, and 19.07% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 5.52% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 17.16% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 9.61% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -0.08% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -1.95% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -231.74% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -2.80% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -155,738.13% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -15,211.11% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.16% |
| Mar 31, 2026 | 17.53% |
| Dec 31, 2025 | 19.07% |
| Sep 30, 2025 | 16.84% |
| Jun 30, 2025 | 14.96% |
| Mar 31, 2025 | 20.52% |
| Dec 31, 2024 | 21.81% |
| Sep 30, 2024 | 18.08% |
| Jun 30, 2024 | 16.73% |
| Mar 31, 2024 | 20.07% |
| Dec 31, 2023 | 15.71% |
| Sep 30, 2023 | 14.32% |
| Jun 30, 2023 | 13.25% |
| Mar 31, 2023 | 16.79% |
| Dec 31, 2022 | 17.42% |
| Sep 30, 2022 | 17.21% |
| Jun 30, 2022 | 14.05% |
| Mar 31, 2022 | 18.53% |
| Dec 31, 2021 | 16.22% |
| Sep 30, 2021 | 16.43% |